Trial
NCT01019707
Safety Assessment of Atomoxetine With MA IV Administration
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Los Angeles
Collaborators
National Institute on Drug Abuse (NIDA)
Condition
Methamphetamine Abuse
Intervention
Atomoxetine, then Placebo
Why stopped
End in funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-02